Moderna (MRNA) PT Raised to $38 at BofA Securities
Tweet
Share
E-mailGet Alerts MRNA Hot Sheet
Price: $145.13 +8.86%
Rating Summary:
6 Buy, 21 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Rating Summary:
6 Buy, 21 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Join SI Premium – FREE
BofA Securities analyst Alec Stranahan raised the price target on Moderna (NASDAQ: MRNA) to $38.00 (from $34.00) while maintaining a Underperform rating.
You May Also Be Interested In
- Moderna (MRNA) PT Raised to $77 at JPMorgan
- Active options: MRNA AMD AVGO PLTR GOOGL NFLX PFE SOFI NBIS COIN
- BofA upgrades Moderna after 177% rally driven by cancer vaccine breakthrough
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
